Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Vonoprazan
The First People's Hospital of Lianyungang
Ulcers, Gastric
1 trial -
Vonoprazan
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
2 trials -
Vonoprazan
Takeda
Reflux Esophagitis
1 trial -
Vonoprazan
Takeda
Erosive Esophagitis
3 trials -
Vonoprazan and Amoxicillin for the first 7 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
lubiprostone (Amitiza)
Takeda
Colonoscopy
1 trial -
CT colonoscopy(normal dose)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Polyps
1 trial -
Chronotropic Incompetence Diagnostic Algorithm
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
Citrus Limonoid Beverage
United Therapeutics Europe Ltd
Hypercholesterolemia
1 trial -
Colonoscopy
Takeda
CD
2 trials -
Dexmedetomidine group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colonoscopy
1 trial -
Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
Intravenous Anesthetic Induction with Ciprofol for Painless Colonoscopy in Elderly Patients
The First People's Hospital of Lianyungang
Ciprofol
1 trial -
Mononuclear cells
Shandong Provincial Hospital
Chronic Atrophic Gastritis
1 trial -
NanoDOX 1% doxycycline monohydrate Hydrogel
United Therapeutics Europe Ltd
Dehisced Surgical Wounds
1 trial -
P2Y12 antagonist monotherapy
Vera Therapeutics
Coronary Artery Disease
1 trial -
Polyethylene glycol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colonoscopy
1 trial -
Ticagrelor monotherapy
The First People's Hospital of Lianyungang
Intracranial Aneurysm
1 trial -
Vonoprazan+amoxicillin+doxycycline+bismuth for 14 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Effect Increased
1 trial -
human cord blood-derived mononuclear cells (HCB-MNCs)
The First People's Hospital of Lianyungang
Refractory Diabetic Foot
1 trial -
lubiprostone
Takeda
Bowel Preparation for Colonoscopy
1 trial -
pre-packaged low-residue diet for bowel preparation
The First People's Hospital of Lianyungang
Colonoscopy: Bowel Preparation
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources